A series of video interviews with Dutch key opinion leaders on the latest scientific insights and clinical data surrounding diagnostic and treatment of hematological diseases, such as CML, AML, ITP, myelofibrosis.
Novartis Pharma Netherlands BV
CML, AML, MF, ITP
Hematologists, hemato-oncologists and hematology students.
Providing education and the latest scientific information with a clinical point a view.
The video-interviews are published on the Hematalks platform, operated by Novartis Pharma Netherlands, and new videos are added monthly. The website is often visited and appreciated by the target audience.